YAP1 and obstructive sleep apnea syndrome: Assessment of pSmad2, TAZ and YAP proteins alone or in combination in a trial TMA suggests a potential benefit of using pSmad2 and YAP combined as prognostic markers for canine OSA, with low levels of both possibly indicating better prognosis.